Acetoacetic acid is a ketone body produced in the liver during the breakdown of fatty acids, especially under conditions of low carbohydrate availability such as fasting, prolonged exercise, and metabolic stress.
It serves as an alternative energy source when glucose is scarce, converting fatty acids into energy.
Acetoacetic acid, along with other ketone bodies like 3-beta-hydroxybutyrate and acetone, plays a crucial role in providing energy to the brain, heart, and skeletal muscles during periods of glucose deficiency.
Elevated acetoacetic acid levels are significant in diagnosing ketoacidosis, particularly diabetic and alcoholic ketoacidosis, and in differentiating types of hypoglycemia.
In some physiological conditions, such as pregnancy and fasting, acetoacetic acid levels may rise without indicating disease.
Testing acetoacetic acid levels in blood or urine is essential for monitoring and managing metabolic conditions, especially in diabetic patients during acute illness, stress, or persistent hyperglycemia.
Acetoacetic acid is a ketone body and a weak organic acid produced in the liver during the breakdown of fatty acids, particularly under conditions of poor glucose metabolism like diabetic ketoacidosis or glycogen storage diseases.
It is also produced in situations of low carbohydrate availability that may include fasting, starvation, prolonged exercise, alcoholism, or when an individual follows a ketogenic diet.
Levels may also rise in pregnancy, without causing acidosis.
The three ketone bodies produced in humans (primarily in the liver and kidney cortex) and excreted in urine are acetoacetic acid, 3-beta-hydroxybutyrate, and acetone. Acetoacetic acid and 3-beta-hydroxybutyrate are the primary ketone bodies used by the body for energy.
Acetoacetic acid is produced during the metabolism of fatty acids, particularly under conditions of low carbohydrate availability, such as fasting, prolonged exercise, or diabetes. It serves as an alternative energy source when glucose is scarce.
Acetoacetic acid is a precursor to acetone, which is excreted through urine or respiration, and it can also be converted to 3-beta-hydroxybutyrate (3HB), another ketone body.
Ketone bodies, including acetoacetic acid, are crucial for providing energy to the brain, heart, and other tissues such as skeletal muscle during periods of glucose deficiency.
Acetoacetic acid is also utilized for synthesizing vital lipids in the brain and lungs, especially during early development.
In diabetic ketoacidosis (DKA), high levels of acetoacetic acid and 3HB accumulate due to low insulin and high counterregulatory hormones.
Traditional tests for ketone bodies often measure acetoacetic acid levels in urine and blood, but newer quantitative tests for 3HB offer more accurate monitoring of ketone levels, particularly useful in managing diabetes and other metabolic conditions.
Historically, acetoacetic acid was discovered in 1865 in the urine of diabetic patients, and its role in metabolism has been extensively studied, highlighting its importance in conditions requiring alternative energy sources.
Acetoacetic acid is primarily produced in the liver through the process of ketogenesis, which occurs when carbohydrate intake is low, and the body shifts to using fat as its primary energy source.
During this process, fatty acids are broken down into acetyl-CoA, which is then converted into acetoacetic acid. This compound can either be used directly for energy or further metabolized into beta-hydroxybutyrate and acetone, other key ketone bodies.
These ketone bodies are then transported to various tissues, including the brain, where they are utilized as an alternative energy source to glucose.
In newborns, mild hyperketonemia is common as ketone bodies are an important energy source for the brain and lungs.
Acetoacetic acid and 3-beta-hydroxybutyrate are important for synthesizing cholesterol, fatty acids, and complex lipids during early development, especially for brain growth and myelination.
In the lungs, acetoacetic acid is a preferred precursor for surfactant phospholipids, essential for lung function in early life.
Production of Ketone Bodies in Diabetes
In diabetic ketoacidosis (DKA), high levels of ketone bodies are produced due to the metabolic shift caused by insulin deficiency.
Ketone bodies are used as an energy source when glucose is not readily available to the cells.
In diabetes, particularly in DKA, low insulin levels and high levels of counter-regulatory hormones (glucagon, catecholamines, cortisol, and growth hormone) stimulate lipolysis in adipose tissue and the production of high levels of ketone bodies.
The breakdown of triglycerides to free fatty acids (FFA) in adipose tissue provides the substrates for ketogenesis in the liver.
Metabolism of Ketone Bodies in DKA
The main ketone bodies are acetoacetate, 3-β-hydroxybutyrate (3HB), and acetone.
Acetoacetate accumulates during fatty acid metabolism under low carbohydrate conditions, and 3HB is formed from the reduction of acetoacetic acid in the mitochondria.
This results in an increased ketone body ratio (3HB) rising from normal (1:1) to as high as 10:1.
Clinical Implications
Elevated ketone bodies, particularly acetoacetic acid and 3HB, are markers of metabolic acidosis in DKA.
The ratio of 3HB to acetoacetic acid is an important indicator of the redox state within hepatic mitochondria and the severity of ketoacidosis. That’s because, as beta-oxidation of the large influx of free fatty acids occurs in hepatic mitochondria, a large amount of NAD+ is reduced to NADH.
This increase in NADH levels favors the conversion of acetoacetate (acetoacetic acid) to 3-β-hydroxybutyrate (3HB) by the enzyme 3-hydroxybutyrate dehydrogenase, which uses NADH as a cofactor.
The resulting increase in 3HB levels increases the 3HB/acetoacetic acid ratio.
This high ratio is a marker of the severity of the metabolic disturbance in DKA and helps in monitoring the response to treatment, as the ratio normalizes with effective therapy.
Measurement of blood ketone levels, particularly 3HB, can provide more accurate monitoring of DKA and its treatment compared to urine ketone tests.
Testing acetoacetic acid levels is essential for diagnosing and managing ketoacidosis and differentiating types of hypoglycemia.
Diabetic Ketoacidosis (DKA)
Acetoacetic acid testing helps diagnose DKA, characterized by hyperglycemia, anion gap metabolic acidosis, and ketonemia. It serves as an indirect measure of acidosis severity, especially when β-hydroxybutyrate testing is impractical.
Alcoholic Ketoacidosis
Acetoacetic acid testing is used to identify metabolic acidosis with an elevated anion gap and high serum ketone levels in patients with excessive alcohol intake.
Hypoglycemia Differentiation
Elevated acetoacetic acid levels help differentiate hypoglycemia due to limited carbohydrate intake (which induces ketogenesis) from insulin-induced hypoglycemia.
Physiologic Conditions
Elevated acetoacetic acid levels during pregnancy and fasting do not necessarily indicate disease.
Monitoring Energy Metabolism
Urine ketone testing is useful for monitoring type 1 diabetes mellitus patients during acute illness, stress, pregnancy, or persistent hyperglycemia.
Hemodialysis Patients
A low arterial acetoacetic acid/β-hydroxybutyrate ratio may indicate increased mortality risk due to poor nutritional status. [3.]
Testing acetoacetic acid levels is crucial for diagnosing and managing ketoacidosis, differentiating types of hypoglycemia, and monitoring metabolic conditions in specific patient populations.
Testing for acetoacetic acid levels can be done in the blood or urine.
The nitroprusside test is widely used for detecting ketones in urine.
Blood testing requires a venipuncture, while urine samples may be collected at home or in a clinical setting.
Special preparation is typically not required, although this should be confirmed with the ordering provider.
Optimal levels of acetoacetic acid in blood are given by one company as: 5-30 µg/mL [1.]
Optimal levels of acetoacetic acid in urine are given by one company as: </= 10 (mmol/mol creatinine) [7.]
Small levels of acetoacetic acid may be produced by the body in the absence of overt metabolic disease.
Elevated acetoacetic acid levels in blood or urine indicate increased ketone body production, which can be seen in situations involving decreased carbohydrate availability as in starvation, fasting, prolonged exercise, or alcoholism.
They can also be seen in metabolic diseases such as uncontrolled diabetes or glycogen storage diseases.
Rarely, decreased acetoacetic acid levels are indicative of fatty acid oxidation disorders. [6.]
Click here to compare testing options and order testing for acetoacetic acid.
[1.] Acetoacetate: Reference Range, Interpretation, Collection and Panels. eMedicine. Published online June 13, 2023. https://emedicine.medscape.com/article/2087135-overview?form=fpf#a2
[2.] Human Metabolome Database: Showing metabocard for Acetoacetic acid (HMDB0000060). hmdb.ca. https://hmdb.ca/metabolites/HMDB0000060
[3.] Inaba M, Kumeda Y, Yamada S, Toi N, Hamai C, Noguchi K, Yasuda E, Furumitsu Y, Emoto M, Ohno Y. Association of higher arterial ketone body ratio (acetoacetate/β-hydroxybutyrate) with relevant nutritional marker in hemodialysis patients. BMC Nephrol. 2020 Nov 25;21(1):510. doi: 10.1186/s12882-020-02173-1. PMID: 33238897; PMCID: PMC7690103.
[4.] Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999 Nov-Dec;15(6):412-26. doi: 10.1002/(sici)1520-7560(199911/12)15:6<412::aid-dmrr72>3.0.co;2-8. PMID: 10634967.
[5.] Owen, O. Ketone Bodies. wwwsciencedirectcom. Published online January 1, 2004:125-136. doi:https://doi.org/10.1016/B0-12-475570-4/01447-5
[6.] Ruiz-Sala P, Peña-Quintana L. Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases. J Clin Med. 2021 Oct 22;10(21):4855. doi: 10.3390/jcm10214855. PMID: 34768374; PMCID: PMC8584803.
[7.] Rupa Health. OAT Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1lA81IDzMs3Q0myMwQR90ypXGCnFzgYGu/view